Skip to main content
Caplight Logo









Anima Biotech

Anima Biotech

Private
Bernardsville, New JerseyHealthcare & Life Scienceshttps://www.animabiotech.com/

Last Round

Strategic

Jan 10, 2023

Total Funding Raised

$226M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Anima Biotech is a biotechnology company that developed the mRNA Lightning platform, which uses AI and visual computing to discover and develop small molecule mRNA drugs.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

AI drug discoverymRNA drug discoverysmall molecule discoveryundruggable targetstechbiodrug discovery platformmRNA modulatorsphenotypic screeningAI image analysismechanism of actionpharmaceutical partnershipsoncology drug discoveryneuroscience drug discoverylive-cell imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anima Biotech Comparables

Compare Anima Biotech with similar companies based on industry and business-model similarity.

Anima Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arrakis Therapeutics
89%
Ribometrix
88%
Wayfinder Biosciences
84%

Anima Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 10, 2023
StrategicMar 18, 2021
StrategicJul 23, 2018
SeedMar 26, 2018

Key People

Founding team and executive leadership

Iris Alroy

Co-Founder & Chief Scientific Officer

Founding Team

Yochi Slonim

Co-founder And CEO

Founding Team

Avi Eliassaf

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 43% MoM.

  • May 15, 2026

    Monthly visitors increased 145% MoM, reaching 6.1K.

Anima Biotech Filings

Explore SEC and related filing metadata, where available.

Anima Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Anima Biotech's valuation, stock price, and market status.

Is Anima Biotech a public or private company?

Anima Biotech is a private company.

What is the current stock price of Anima Biotech?

Anima Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Anima Biotech worth (valuation)?

Valuation information for Anima Biotech is not publicly available.

Can I buy Anima Biotech stock?

Anima Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Anima Biotech's last funding round?

Anima Biotech's most recent funding round was Strategic on January 10, 2023.

Who are the main investors in Anima Biotech?

Investor information for Anima Biotech is not publicly disclosed.

Will Anima Biotech IPO soon?

No public IPO plans have been announced for Anima Biotech.

How can I track Anima Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anima Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBernardsville, New Jersey
Employee Range56
Year Founded2014
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?